Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

TerrAscend Corp. (C:TER)

Business Focus: Alternative Medicine

Sector:  Healthcare Industry:  Pharmaceuticals
See Regulatory Filings on SEDAR
Company Contact
Address: 3610 Mavis Rd
Tel: N/A
IR: See website
Key People
Jason Ackerman
Interim Chief Executive Officer, Executive Chairman of the Board
Adam Kozak
Chief Financial Officer
Heather Molloy
Executive Vice President, Chief Strategy Officer
Joanna Halligan
Vice President of Human Resources
Brian M. Feldman
General Counsel
Business Overview
TerrAscend Corp is a Canada-based company engaged in providing products, brands, and services to the cannabinoid market. The Company, through its subsidiary TerrAscend Canada Inc., is a producer of medical and adult use cannabis. It also operates through various businesses, including The Apothecarium, a cannabis dispensary with retail locations in California and Nevada; Arise Bioscience Inc., a manufacturer and distributor of hemp-derived products; Ascendant Laboratories Inc., a biotechnology and licensing company focused on cannabinoid expressing plants; Solace RX Inc., a Drug Preparation Premises (DPP) focused on the development of formulations and delivery forms; and Valhalla Confections, a manufacturer of premium cannabis-infused edibles.
Financial Overview
For the six months ended 30 June 2020, Terrascend Corp revenues increased from C$32.2M to C$82M. Net loss decreased 13% to C$25.9M. Revenues reflect United States segment increase from C$16M to C$73.2M. Lower net loss reflects Unrealized loss (gain) on investments decrease of 87% to C$333K (expense). Basic Earnings per Share excluding Extraordinary Items increased from -C$0.59 to -C$0.18.
Reporting Currency: Canadian Dollars
Enterprise value: $641.21M as of Jun 30, 2020
Annual revenue (TTM): $134.74M as of Jun 30, 2020
EBITDA (TTM): -$8.64M as of Jun 30, 2020
Net annual income (TTM): -$211.90M as of Jun 30, 2020
Free cash flow (TTM): -$56.22M as of Jun 30, 2020
Net Debt Last Fiscal Year: $39.71M as of Jun 30, 2020
Shares outstanding: 99,336,211 as of Jun 30, 2020
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization